NewsRx Logo Login/Signup
Home Newsletters Products Library About Us Contact -- Search NewsRx

NewsRx | Free Trials
Advertisement
VerticalNews | Global Warming
NewsRx | Free Newsletters
 
----------
------------
NewsRx on Facebook
-----
NewsRx Passes
Press Release Submissions
PR Login
-----
2008 Award Logo
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005
-----
Google 2009 PageRank: #2 Among Top Health News and Media Publications
Google 2009 PageRank: #2 Among Top Science Publications in Biology/Physiology
Google 2009 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
Amazon's Alexa 2009 PageRank: #2 News and Media Site for the Pharmaceutical Industry
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.

This website is certified by Health On the Net Foundation. Click to verify. This site complies with the HONcode standard for trustworthy health information:
verify here.

Security by Verisign

Search Results for HepaLife Technologies Inc


Filter Articles: Clinical News | Consumer News | Business News | All News | More Options

Results 1 - 20      Next >


Refine Search
Display Mode: Context | Summary
HepaLife™ Plans for Phase III Clinical Trial for HepaMate™ Bioartificial Liver System
2009 MAR 2 ... HepaLife Technologies, Inc. (OTCBB: HPLF) (FWB: HL1) (WKN: 500625), developing its cell-based ...
Subject: HepaLife Technologies
Price: $3.00
*
Independent Report Projects HepaLife as a Leader in $1.5 Billion Liver Assist Market.
2009 JUL 6 ... management team. ABOUT HEPALIFE TECHNOLOGIES, INC. Based in Boston, Massachusetts, HepaLife Technologies Inc., is developing its cell-based bioartificial liver system, HepaMate, as a potentially ...
Subject: HepaLife Technologies, Inc.
Price: $3.00
*
Accomplished Executive with Regulatory Affairs/Quality Systems & Bioartificial Liver Device Expertise Joins HepaLife(TM)
2008 MAR 24 ... Treatment, U.S. Food and Drug Administration, Xenotransplantation, Xenotransplantion, HepaLife Technologies Inc. This article was prepared by Biotech Business Week editors from staff ...
Subject: Bioartificial Liver
Price: $3.00
*
Arbios Sells HepatAssist Bioartificial Liver System to HepaLife Technologies, Inc.
2008 OCT 20 ... has sold all its rights and interest in its bioartificial liver system, HepatAssist, to HepaLife Technologies, Inc. (BULLETIN BOARD: HPLF) , a Boston-based biotechnology company ...
Subject: Bioartificial Liver
Price: $3.00
*
HepaLife Achieves 20-Fold Increase in Cell Production for Bioartificial Liver While Reducing Labor 4-Fold
2008 AUG 18 ... Actions, Regulatory Actions, Stem Cell Research, U.S. Food and Drug Administration, HepaLife Technologies Inc. This article was prepared by Biotech Business Week editors from staff ...
Subject: HepaLife Technologies, Inc.
Price: $3.00
*
HepaLife Completes $4.5 Million Private Placement
2008 JUN 9 ... HepaLife Technologies, Inc. (OTCBB:HPLF) (FWB:HL1) (WKN:500625) developing the first-of-its-kind ...
Subject: HepaLife Technologies, Inc.
Price: $3.00
*
HepaLife Develops New Liver Stem Cell Lines for Bioartificial Liver Device; Data Presented at Scientific Conferences
2008 JUL 14 ... Patents Actions, Protein Synthesis, Proteomics, Stem Cell Research, Transpeptidase, HepaLife Technologies Inc. This article was prepared by Biotech Business Week editors from staff ...
Subject: HepaLife Technologies, Inc.
Price: $3.00
*
HepaLife's Bioartificial Liver Dramatically Reduces Toxic Marker for Acute Liver Failure
2008 FEB 25 ... Liver Failure, Medical Device, Organ Transplant, Patents Actions, Stem Cell Research, HepaLife Technologies Inc. This article was prepared by Gastroenterology Week editors from staff ...
Subject: Bioartificial Liver
Price: $3.00
*
HepaLife's Bioartificial Liver Exceeds Expectations in New Tests Conducted over Prolonged Periods of Time
2008 MAY 26 ... Liver Support, Medical Device, Organ Transplant, Patents Actions, Therapy, Treatment, HepaLife Technologies Inc. This article was prepared by Biotech Business Week editors from staff ...
Subject: HepaLife Technologies, Inc.
Price: $3.00
*
HepaLife's Bioartificial Liver Successful in Important Studies Modeling Human Liver Failure Environment
2008 APR 21 ... Liver Failure, Liver Function, Medical Device, Organ Transplant, Patents Actions, HepaLife Technologies Inc. This article was prepared by Gastroenterology Week editors from staff ...
Subject: Bioartificial Liver
Price: $3.00
*
HepaLife(TM) Announces Exclusive License Agreement with U.S. Government Agency for Liver Cell Lines
2007 NOV 19 ... Bioengineering, Biomedical Engineering, Biomedicine, Medical Device, Organ Transplant, HepaLife Technologies Inc. This article was prepared by Hematology Week editors from staff and ...
Subject: Artificial Liver
Price: $3.00
*
HepaLife(TM) Enters Into New Cooperative Research and Development Agreement with U.S. Government Agency
2007 DEC 10 ... Biomedicine, Biotechnology, Medical Device, Organ Transplant, Stem Cell Research, HepaLife Technologies Inc. This article was prepared by Biotech Business Week editors from staff ...
Subject: Bioartificial Liver
Price: $3.00
*
HepaLife(TM) Releases Positive New Research Results for First-of-Its-Kind Bioartificial Liver
2007 OCT 8 ... Bioreactors, Biotechnology, Medical Device, Organ Transplant, Regulatory Actions, HepaLife Technologies Inc. This article was prepared by Biotech Business Week editors from staff ...
Subject: Bioartificial Liver
Price: $3.00
*
HepaLife(TM) Surpasses Significant Milestones in Development of Artificial Liver Device
2007 DEC 31 ... Device, Organ Transplant, Patents Actions, Perfusion, Stem Cell Research, Xenobiotics, HepaLife Technologies Inc. This article was prepared by Biotech Business Week editors from staff ...
Subject: Bioartificial Liver
Price: $3.00
*
HepaLife(TM) to Present Bioartificial Liver Device Data at International Stem Cell Conference
2008 APR 28 ... Liver Function, Medical Device, Organ Transplant, Patents Actions, Stem Cell Research, HepaLife Technologies Inc. This article was prepared by Gastroenterology Week editors from staff ...
Subject: Bioartificial Liver
Price: $3.00
*
HepaLife(TM) to Present New Bioartificial Liver Device Data at Major National Scientific Conference
2008 APR 7 ... Biomedicine, Biotechnology, Medical Device, Organ Transplant, Therapy, Treatment, HepaLife Technologies Inc. This article was prepared by Biotech Business Week editors from staff ...
Subject: Biomedicine
Price: $3.00
*

Results 1 - 20      Next >




-----------------------
PR Login